Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menveo vs Menomune in children 2-10 years
NCT00329849Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2006
- Primary completion
- Mar 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen in meningococcal disease, sponsored by Novartis. Started May 2006; status: completed.
02
Drugs
neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT00329849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329849.